Essential Thrombocythemia
Hydroxyurea for Patients with Essential Thrombocythemia and a High Risk of Thrombosis | NEJM
How we diagnose and treat essential thrombocythaemia - Alimam - 2015 - British Journal of Haematology - Wiley Online Library
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study - The Lancet
Management of Essential Thrombocythemia: Implications of the Medical Research Council Primary Thrombocythemia 1 Trial
Association of non-malignant diseases with thrombocytosis: a prospective cohort study in general practice | British Journal of General Practice
Advancing Our Clinical Perspectives in Haematology – What is Your Approach? - touchONCOLOGY
Risk stratification of patients with essential thrombocythemia: therapeutic implications
PDF) Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study | Claire Harrison - Academia.edu
Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation | Haematologica
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature - ScienceDirect
Essential Thrombocythemia
Nordic care program for patients with Essential Thrombocythemia, Polycythemia Vera and Primary Myelofibrosis
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE
Bone marrow trephine biopsy findings in essential thrombocythemia - Flora - 2011 - American Journal of Hematology - Wiley Online Library
Network Guidelines new version MPN
ESSENTIAL THROMBOCYTHEMIA (ET) – MPN Research Foundation
Acute Leukaemias and Myeloid Neoplasms Part 4: Myeloproliferative Neoplasms
Advancing Our Clinical Perspectives in Haematology – What is Your Approach? - touchONCOLOGY
Fifty-five essential thrombocythemia patients follow-up study in single institution of Japan
Essential thrombocythaemia and its neurological complications | Practical Neurology
HYDROXYCARBAMIDE – MYELOPROLIFERATIVE NEOPLASMS
ESSENTIAL THROMBOCYTHEMIA (ET) – MPN Research Foundation
Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review. - Abstract - Europe PMC
Main clinical characteristics of 891 patients with WHO- defined... | Download Table
Essential thrombocythemia - Wikipedia
